Physician profile
Anthony Kam
NPI 1740376383
$2,742.60
in general payments reported to CMS, 2019-2025
12 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $32.43 · 2021: $486 · 2022: $460 · 2023: $368 · 2024: $358 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,061.24 | 2019-2025 | Broadway 8, Spinejack |
| Depuy Synthes Sales INC. | $370.36 | 2022-2025 | Embotrap |
| Penumbra, INC. | $363.85 | 2023-2024 | Red 72, Penumbra Coil 400 |
| Microvention, INC. | $344.18 | 2019-2025 | Tubing Kit - Stroke, Web Aneurysm Embolization System, Sofia 6f-131cm Str |
| Medical Device Business Services, INC. | $217.31 | 2022 | |
| Medtronic, INC. | $197.40 | 2021 | |
| Balt USA, LLC | $58.65 | 2025 | Optima Coil System |
| Boston Scientific Corporation | $52.63 | 2024 | |
| Medtronic USA, INC. | $20.91 | 2019 | |
| Terumo Medical Corporation | $19.67 | 2023 | Angio-Seal |
| Cordis US Corp. | $19.64 | 2025 | Mynx Control Venous |
| Abbott Laboratories | $16.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Kam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.